Verified Investing on $SMMT (Nov 16, 2026)
SMMT closed below its low-range pivot point, signaling a slight chart decline; the likely move is a correction to the 786 Fibonacci level at $9.54, where the prior advance began. RSI is 34.91, and reaching $9.54 would likely test the 30 near-term oversold level, necessitating a technical bounce.
Playing via YouTube may share device and playback data and use cookies. Privacy Notice · Google Privacy Policy
Jump to any passage
This was Summit Therapeutics' stock, which fell by 16.47%. One percent today. More importantly, the stock closed today below the low-range pivot point . This tells me that SMMT stock is heading for a slight decline on the charts.
When you draw these Fibonacci retracement tools beforehand, you can see quite clearly, without needing to draw any other trend lines, that the 786 level at $9.54 corresponds to the previous price action that broke through that range, then fell back, gained momentum, and then surged upwards again.
So, this is simply a correction to the level from which the price previously started, which tells me that this is the likely direction of price movement. Look, we are at 34.91 on the Relative Strength Index (RSI).
If we reach that level of 786, we will certainly test the 30 range, which is the near-term oversold level , which necessitates a technical bounce. You need a technical reason. That is precisely the reason .
That level is 786 Fibonacci retracement at $9.54.